Proof of Usefulness Report

Celaid Therapeutics

Analysis completed on 2/14/2026

+305
Proof of Usefulness Score
Certified Problem Solver

Celaid Therapeutics is a legitimate, high-potential Series B biotechnology company (approx. $17M verified funding) developing novel hematopoietic stem cell expansion technology. However, the submission quality is critically low, containing a mismatched name ('IronForge'), false traction claims ('most people have used my product'), and generic data. The score reflects the project's high verified utility and innovation, heavily penalized by the lack of credible evidence in the submission itself.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+112.5
Audience Reach Impact+20.0
Technical Innovation+67.5
Evidence Of Traction+50.0
Market Timing Relevance+42.5
Functional Completeness+2.5
Subtotal+295
Usefulness Multiplierx1.03
Final Score+305

Project Details

Project URL
celaidtx.com
Description
Celaid Therapeutics is a Japan-based biotechnology company, which has developed a platform technology to efficiently expand hematopoietic stem cells ex vivo without choosing its origins, including bone marrow, cord blood, or peripheral blood. By using the novel technology, we are developing a cell therapy product that brings HSC transplantation to the next level and helps patients with blood disorders. Our technology has many potential applications including gene/cell therapy that utilize gene editing on HSC. Our mission is to improve QOL of patients, their families, and HSC donors all over the world.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline